Home NDC 76074-152 MEDI-DERM / L WITH LIDOCAINE
Product NDC 76074-152
11-digit product format 760740152
Labeler code 76074
Product ID 76074-152_50ac7b86-dcd2-4cea-afd3-f16f3d1a5110
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE
Dosage form CREAM
Route TOPICAL
Labeler Two Hip Consulting, LLC
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2012-08-18
Marketing end 0000-00-00
Substance METHYL SALICYLATE; MENTHOL; CAPSAICIN; LIDOCAINE
Active strength 20 g/100mL; g/100mL; g/100mL; g/100mL
Pharmacologic classes Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 76074-152-14 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 76074-152-14 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 76074-152-14 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 76074-152-14 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 76074-152-14 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 76074-152-14 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 76074-152-14 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 76074-152-14 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 76074-152-14 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 76074-152-14 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 76074-152-14 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 76074-152-14 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 76074-152-14 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 76074-152-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 76074-152-14 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 76074-152-14 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 76074-152-14 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 76074-152-14 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 76074-152-14 8dfbde2a14a4…c9ff85d89658…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 76074-152-14 MEDI-DERM / L WITH LIDOCAINERX 120 mL in 1 TUBE CREAM 120 5
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CAPSAICIN ACTIVE INGREDIENT S07O44R1ZM MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 LIDOCAINE ACTIVE INGREDIENT 98PI200987 MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 MENTHOL ACTIVE INGREDIENT L7T10EIP3A MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 METHYL SALICYLATE ACTIVE INGREDIENT LAV5U5022Y MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 CAPSAICIN ACTIVE MOIETY S07O44R1ZM MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 LIDOCAINE ACTIVE MOIETY 98PI200987 MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 MENTHOL ACTIVE MOIETY L7T10EIP3A MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 SALICYLIC ACID ACTIVE MOIETY O414PZ4LPZ MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 CARBOMER 934 INACTIVE INGREDIENT Z135WT9208 MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 CETOSTEARYL ALCOHOL INACTIVE INGREDIENT 2DMT128M1S MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 CYPERUS ESCULENTUS LEAF INACTIVE INGREDIENT T1004HC0OF MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 GLYCERYL MONOSTEARATE INACTIVE INGREDIENT 230OU9XXE4 MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 HYPROMELLOSE 2208 (100000 MPA.S) INACTIVE INGREDIENT VM7F0B23ZI MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 ISOPROPYL PALMITATE INACTIVE INGREDIENT 8CRQ2TH63M MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 METHYLISOTHIAZOLINONE INACTIVE INGREDIENT 229D0E1QFA MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 POLYSORBATE 60 INACTIVE INGREDIENT CAL22UVI4M MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 STEARYL ALCOHOL INACTIVE INGREDIENT 2KR89I4H1Y MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4 WATER INACTIVE INGREDIENT 059QF0KO0R MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 76074-152 MEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC] 5 Legacy NDC, 1 package rows 20190207_a1eced33-f9ee-4757-ab94-75f238f9b2a9.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 76074-152-14 76074015214 120 mL in 1 TUBE 120 ml Historical